[Medically managed delivery under CT 1341 (althesin (Glaxo)) anesthesia].
The Authors, after illustrating the pharmacological and physiological characteristics of CT 1341 (Althesin Glaxo), have experimented this medicine in medico-piloted delivery under narcosis on two homogenous groups of 20 patients each. The Authors have evidenced the lack of any harmful effect on the proceeding of labour, the viability of the infant, the delivery of the placenta and on post-partum, provided that a time of induction not too premature with regard to the evolution of labour be respected.
D000293:Adolescent; D000328:Adult; D000530:Alfaxalone Alfadolone Mixture / Q000009:adverse effects; D000771:Anesthesia, Intravenous / Q000379:methods*; D000773:Anesthesia, Obstetrical / Q000379:methods*; D001034:Apgar Score; D002986:Clinical Trials as Topic; D036861:Delivery, Obstetric / Q000379:methods*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D010298:Parity; D011247:Pregnancy
D000530:Alfaxalone Alfadolone Mixture
Il parto medico pilotato in narcosi con CT 1341 (althesin Glaxo).